German biotech Kupando raises €10M more to take its innate immunity drug into the clinic
An extension to the company’s Series A brings total funding to €23 million and clears the path for the first human trial of KUP101, a dual TLR agonist targeting solid tumours and drug-resistant infections. Most immunotherapy research in oncology has concentrated on the adaptive immune system, the learned, antibody-generating machinery that checkpoint inhibitors like pembrolizumab […]<br /> This story continues at The Next Web [...]
Rating
Innovation
Pricing
Technology
Usability
We have discovered similar tools to what you are looking for. Check out our suggestions for similar AI tools.
Stanford is running 37,000 AI agents as a virtual biotech — and one of its drug designs got independently confirmed by Merck
For developers, the operating assumption has been one engineer, one agent — the model Claude Code and similar tools. At VB Transform 2026, James Zou, associate professor of biomedical data science a [...]
German AI consortium releases Soofi S, an open 30B model that tops benchmarks in both English and German
A German research consortium has released Soofi S 30B-A3B, an open language model trained entirely on Deutsche Telekom's cloud infrastructure in Munich. The model uses an efficient hybrid archite [...]
EU Parliament strips immunity from senior Italian MEP in Huawei bribery probe
The European Parliament voted on Tuesday to lift the parliamentary immunity of Fulvio Martusciello, clearing the way for Belgian prosecutors to pursue bribery allegations linked to Chinese tech giant [...]
Microsoft AI chief says company was “set free” from OpenAI to pursue superintelligence
For three years, Microsoft's artificial intelligence story has been inseparable from OpenAI. The partnership — cemented by a cumulative investment exceeding $13 billion — gave Microsoft early [...]
Lumai Raises $10M+ to Revolutionize AI Compute with Optical Processing
In a major leap forward for the future of artificial intelligence infrastructure, Lumai, the Oxford-born startup pioneering 3D optical computing, has raised more than $10 million in a fresh funding ro [...]
Akeso’s lung cancer drug reduces death risk by 34%, marking the first Chinese drug at ASCO’s top stage in 61 years
Akeso, the Chinese biotechnology company whose drug ivonescimab was dubbed “biotech’s DeepSeek moment” last year, has reported phase three clinical trial results showing a 34% reduction in the r [...]
Stanford researchers will discuss their agentic 'scientists' that are on course to reshape drug discovery at VB Transform 2026
Drug discovery is notoriously inefficient. Pharmaceutical projects span years, moving from one specialized human team to the next through disconnected workflows that result in knowledge loss during ea [...]
German Bionic’s new Apogee Ultra exoskeleton can lift up to 80 pounds and help with walking
German Bionic, the robot exoskeleton startup behind the lightweight Apogee exosuit, just revealed the Apogee Ultra at CES 2025 in Las Vegas. This powered exoskeleton is intended to help people complet [...]